Calcium signaling in systemic lupus erythematosus T cells: a treatment target
about
Disturbed T Cell Signaling and Altered Th17 and Regulatory T Cell Subsets in the Pathogenesis of Systemic Lupus ErythematosusSmall molecules in the treatment of systemic lupus erythematosusEstradiol differentially regulates calreticulin: a potential link with abnormal T cell function in systemic lupus erythematosus?Reducing FLI1 levels in the MRL/lpr lupus mouse model impacts T cell function by modulating glycosphingolipid metabolismTargeting lymphocyte signaling pathways as a therapeutic approach to systemic lupus erythematosus.Manipulating autophagic processes in autoimmune diseases: a special focus on modulating chaperone-mediated autophagy, an emerging therapeutic target.T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity.Lupus nephritis: an overview of recent findings.Metabolic regulation of organelle homeostasis in lupus T cellsRNA-seq Analysis Reveals Unique Transcriptome Signatures in Systemic Lupus Erythematosus Patients with Distinct Autoantibody SpecificitiesNanovesicle-targeted Kv1.3 knockdown in memory T cells suppresses CD40L expression and memory phenotype.Treatment with anti-interleukin 23 antibody ameliorates disease in lupus-prone miceTreatment of systemic lupus erythematosus: new advances in targeted therapy.NFAT gene family in inflammation and cancer.Treatment of systemic lupus erythematosus: new therapeutic avenues and blind alleys.Epigenetics and Vasculitis: a Comprehensive Review.Low-Dose IL-2 in the Treatment of Lupus.Calcium Signaling: From Normal B Cell Development to Tolerance Breakdown and Autoimmunity.NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells.Hydroxychloroquine inhibits CD154 expression in CD4+ T lymphocytes of systemic lupus erythematosus through NFAT, but not STAT5, signalingAn update on the role of epigenetics in systemic vasculitis.T Cell Calcium Signaling Regulation by the Co-Receptor CD5.Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus.
P2860
Q26773124-CC1237C4-1ACA-4007-816D-A1D69FD1943CQ27010090-309A2C41-5FC3-4E75-926D-41BBF718C00CQ33810803-3A58FD3C-8AAA-4D24-8967-3CA3ED1BE15FQ34990559-21F8A452-D47F-4FA8-B9BC-4F3AAD852A1FQ35172134-6D67DBDE-EDCE-4478-8836-93035698495BQ35622999-E736EDAB-7C10-438F-A70E-F4493CE20A43Q35836112-099FC8A5-36E7-4E9A-A283-B3782ACAED8EQ35867038-1F9F4517-004E-4E78-A541-34AA3A36F551Q36177195-7D2A7165-C3A6-43DE-9E91-F94E30F87F05Q36190001-86821390-E759-4FF8-8E1D-3A1753A0CD40Q36794555-8FD6C8D2-D523-448D-8691-93FE0CDD3482Q36948466-4D211E9F-770B-4F0F-9503-D90E3DDFE967Q37974990-FDB82919-4D01-4626-8C37-DBC59C507435Q38040813-9FED5F26-0A75-4D57-BAAA-B395CFA93ABBQ38150110-897F6B7E-4EE3-45DA-AD78-6A339643B194Q38533019-BABD6837-3CBE-4369-A1FD-684AD1FB264CQ38979253-B2D22BEC-D6A8-4B32-8EB2-0E9946F636BFQ39303549-03822B62-F370-42DC-B5C4-664D2E2E0946Q39738126-4F37C458-520A-45C4-B2F1-D58D4FE97021Q41336601-294A96E1-21BE-468B-B1E2-D8D987B03931Q49672111-0DBFA13D-261C-4397-B847-BB6D91FF766AQ55000833-52A2B052-783A-4A36-A411-8DA34CAF1CB9Q55163735-005B71BD-8BFF-4B55-852E-23028EC39ABB
P2860
Calcium signaling in systemic lupus erythematosus T cells: a treatment target
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Calcium signaling in systemic lupus erythematosus T cells: a treatment target
@ast
Calcium signaling in systemic lupus erythematosus T cells: a treatment target
@en
type
label
Calcium signaling in systemic lupus erythematosus T cells: a treatment target
@ast
Calcium signaling in systemic lupus erythematosus T cells: a treatment target
@en
prefLabel
Calcium signaling in systemic lupus erythematosus T cells: a treatment target
@ast
Calcium signaling in systemic lupus erythematosus T cells: a treatment target
@en
P2093
P2860
P356
P1476
Calcium signaling in systemic lupus erythematosus T cells: a treatment target
@en
P2093
George C Tsokos
Ourania Kampagianni
Vasileios C Kyttaris
Zheng Zhang
P2860
P304
P356
10.1002/ART.30353
P577
2011-07-01T00:00:00Z